Building business value - Resilience in a rapidly evolving global environment

Its definition depends on the target of the value. According to Nobel-winning economist Milton Friedman, shareholders were considered to be the main recipients. Today, however, businesses face pressure to create value for a wider range of stakeholders—employees, customers, the supply chain and the communities in which they operate. This shift expands value beyond what can be measured in purely monetary terms.

Digital public infrastructure: building the rails of the digital revolution

These digital rails facilitate a more inclusive provision of digital goods and services with massive economic returns. These rails usually come in the form of a stack, comprising all the technologies required to operate an application: computer languages, architecture, libraries, servers, user interfaces and experiences, and software.

The Intelligent Transformation Index

The Intelligence Transformation Index explores the usage of Artificial Intelligence, Internet of Things and big data analysis by businesses across 33 countries. As part of the study, a survey of businesses in China was conducted to compare the world’s second largest economy with its OECD peers.

Changing with the times: category management at a crossroads

This report was written by Siddharth Poddar and edited by Pooja Chaudhary and Harsheen Sethi, with support from Amanda Simms on sub-editing. Economist Impact wishes to thank the following experts for their participation in the interview programme:
 
• Alan Day, chairman and founder, State of Flux
• Pardeep Gill, chief procurement officer (CPO) and vice president of supply chain, Ameren
• Phil Ideson, founder and managing director, Art of Procurement
• Lisa Martin, senior vice president, global procurement, and CPO, GSK

Pushing forward: the future of AI in the Middle East and North Africa

In the past decade artificial intelligence (AI) has shifted from the peripheries of policy attention to the centre of investment and political focus. Global investment in AI has soared since 2010, increasing from a mere US$0.8 billion to US$78 billion in 2021–an increase of over nine thousand percent. In 2019, the Economist Intelligence Unit forecasted the economic impact of AI in Saudi Arabia and the UAE, estimating that US$ 200 billion and US$ 122 billion respectively, could be added to the GDP if the governments introduced policies to build talent and capital. 

The super-app model in the Middle East and Africa

The emergence of the next generation of digital challengers—super-apps—has presented a conundrum to incumbent companies, both within and outside the financial sector. Tracing the evolution of super-apps in China shows that their disruptive impact is evident. In this report we ask what lessons this holds for the Middle East and Africa, not just for technology firms poised to become super-apps but also for the incumbents themselves, particularly those in the financial services industry.

Breaking news: the economic impact of covid-19 on the global news media industry

The global news media industry is under threat at a time when access to trustworthy, independent journalism is, for many, a matter of life and death.

ライフサイエンス分野のイノベーション- インフォグラフィック

 

 

 

日本のイノベーティブな ライフサイエンス・エコシステムを支えるために

ライフサイエンス・セクターの医療イノベーションには 、 基礎科学・研 究開発(R&D)・実用化など 、 あらゆる領域を対象とした包括的政策や市 場アクセスが不可欠だ。日本は過去数十年にわたり 、 アジアの主要イノ ベーション国として存在感を示してきた。しかしライフサイエンスにお けるイノベーションでは北米と欧州が依然として大きな影響力を保って いる。また近年 、 韓国や中国がインフラ・人材・R&D への投資を加速さ せ 、 新たな政策を打ち出すことでライフサイエンス領域のエコシステム 強化を推進している。競争力強化に向けた抜本的な方策が日本に求めら れているのはそのためだ。

ザ・エコノミスト・インテリジェンス・ユニット(EIU)が作成した本 報告書では 、 日本のライフサイエンス・セクターの現状を米国・韓国・ 中国と比較分析し 、 イノベーション推進体制のさらなる強化に向けた 方策について検証する。

日本はライフサイエンスの分野で高度なイノベーション力を維持して いるが 、 先行する米国には追い付けていない。またアジアでは韓国・ 中国といった競合国の追い上げに直面しており 、 イノベーション大国と しての地位は必ずしも盤石でない。

Supporting an innovative life sciences ecosystem in Japan

Medical innovation in the life sciences requires a holistic policy and market access environment that supports everything from basic science to product research and development (R&D) and, ultimately, commercialization. Though North America and Europe have historically led innovation in life sciences, Japan has been a leading contributor from Asia for decades.

Enjoy in-depth insights and expert analysis - subscribe to our Perspectives newsletter, delivered every week